CD117 expression influences proliferation but not survival in canine mammary tumours

Journal of Comparative Pathology

Volumn 151, Issue 2-3, 2014, Pages 202-206

  Brunetti, B ^a   Beha, G ^a   Benazzi, C ^a   Bondin, V ^b   De Tolla, L ^c   Sarli, G ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Veterinary Practitioner ^*  (Malta)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

CD117; Dog; Ki67 index; Mammary tumour

Indexed keywords

KI 67 ANTIGEN; STEM CELL FACTOR RECEPTOR; TUMOR MARKER;

ANAPLASTIC CARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST ADENOMA; BREAST ANAPLASTIC CARCINOMA; BREAST BENIGN IN MIXED TUMOR; BREAST CANCER; BREAST CARCINOMA; BREAST CARCINOMA IN BENIGN MIXED TUMOR; BREAST COMPLEX CARCINOMA; BREAST FIBROADENOMA; BREAST HYPERPLASIA; BREAST SQUAMOUS CELL CARCINOMA; BREAST TUBULOPAPILLARY CARCINOMA; BREAST TUMOR; CANCER STAGING; CANCER SURVIVAL; CANINE MODEL; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOPLASM; DOG DISEASE; IMMUNOHISTOCHEMISTRY; NONHUMAN; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; CELL PROLIFERATION; DOG; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; PATHOLOGY;

CANIS FAMILIARIS;

ANIMALS; CELL PROLIFERATION; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MAMMARY NEOPLASMS, ANIMAL; PROTO-ONCOGENE PROTEINS C-KIT; TUMOR MARKERS, BIOLOGICAL;

EID: 84905909477     PISSN: 00219975     EISSN: 15323129     Source Type: Journal    
DOI: 10.1016/j.jcpa.2014.04.018     Document Type: Article

References (15)

1. Chui X., Egami H., Yamashita J., Kurizaki T., Ohmachi H., et al. Immunohistochemical expression of the c-kit protooncogene product in human malignant and non-malignant breast tissues. British Journal of Cancer 1996, 73:1233-1236.
2. Gil da Costa R.M., Matos E., Rema A., Lopes C., Pires A.M., et al. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers. BMC Veterinary Research 2007, 3:19.
3. Gilbertson S.R., Kurzman I.D., Zachrau R.E., Hurvitz A.I., Black M.M. Canine mammary epithelial neoplasms: biologic implications of morphologic characteristics assessed in 232 dogs. Veterinary Pathology 1983, 20:27-42.
4. Gomes J., Queiroga F.L., Prada J., Pires I. Study of c-kit immunoexpression in canine cutaneous melanocytic tumors. Melanoma Research 2012, 22:195-201.
5. Kondi-Pafiti A., Arkadopoulos N., Gennatas C., Michalaki V., Frangou-Plegmenou M., et al. Expression of c-kit in common benign and malignant breast lesions. Tumori 2010, 96:978-984.
6. Kubo K., Matsuyama S., Katayama K., Tsutsumi C., Yonezawa K., et al. Frequent expression of the c-kit proto-oncogene in canine malignant mammary tumor. Journal of Veterinary Medical Science 1998, 60:1335-1340.
7. Misdorp W., Else R.W., Hellmén E., Lipscomb T.P. Histological Classification of Mammary Tumors of the Dog and Cat 1999, Armed Forces Institute of Pathology in Co-operation with the American Registry of Pathology and the World Health Organization Collaborating Centre for Worldwide Adherence on Comparative Oncology, Washington DC.
8. Morini M., Bettini G., Preziosi R., Mandrioli L. C-kit gene product (CD117) immunoreactivity in canine and feline paraffin sections. Journal of Histochemistry and Cytochemistry 2004, 52:705-708.
9. Preziosi R., Morini M., Sarli G. Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog. Journal of Veterinary Diagnostic Investigation 2004, 16:554-561.
10. Regan J.L., Hendrick H., Magnay F.A., Vafaizadeh V., Groner B., et al. C-KIT is required for growth and survival of the cells of origin of Brca-1-mutation-associated breast cancer. Oncogene 2012, 31:869-883.
11. Sailasuta A., Thomrongsuwannakij T., Romphotiyok K., Theeratammakom T., Wangnaitham S. Expression of c-KIT oncogene product in mammary gland tumors in dogs. Proceedings of the 15th FAVA Congress - OIE Joint Symposium on Emerging Diseases, Bangkok, Thailand 2008, 339.
12. Sarli G., Preziosi R., Benazzi C., Castellani G., Marcato P.S. Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors. Journal of Veterinary Diagnostic Investigation 2002, 14:25-34.
13. Tomasino R.M., Morello V., Gullo A., Pompei G., Agnese V., et al. Assessment of 'grading' with Ki-67 and c-kit immunohistochemical expressions may be a helpful tool in management of patients with flat epithelial atipia (FEA) and columnar cell lesions (CCLs) on core breast biopsy. Journal of Cellular Physiology 2009, 221:343-349.
14. Torres-Cabala C.A., Wang W.L., Trent J., Yang D., Chen S., et al. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type. Modern Pathology 2009, 22:1446-1456.
15. Yasuda A., Sawai H., Takahashi H., Ochi N., Matsuo Y., et al. The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells. Molecular Cancer 2006, 5:46.